小分子化合物抑制腫瘤促凝血活性之作用及機轉探討
KY Hsieh - 高雄醫學大學天然藥物研究所博士班學位論文, 2019 - airitilibrary.com
… -induced TF expression in human lung cancer A549 cells. YC-1 … -α-induced TF activity and
enhanced the cytotoxic effect. By … cancer-associated TF expression and procoagulant activity …
enhanced the cytotoxic effect. By … cancer-associated TF expression and procoagulant activity …
[HTML][HTML] 《 胸部恶性肿瘤围术期静脉血栓栓塞症预防中国专家共识（ 2018 版）》 解读之围术期高凝状态篇
崔松平， 李辉 - Chinese Journal of Lung Cancer, 2019 - ncbi.nlm.nih.gov
… 表达癌性促凝因子（cancer procoagulant, CP）、组织因子（tissue factor, TF）、炎症因子… more
accurate and targeted anticoagulation strategies to prevent thrombosis in lung cancer patients…
accurate and targeted anticoagulation strategies to prevent thrombosis in lung cancer patients…
[HTML][HTML] 组织因子与肿瘤患者静脉血栓栓塞
ZHU Huiqi, Y Kejing - Journal of Zhejiang University (Medical …, 2020 - ncbi.nlm.nih.gov
… cells enter the circulation and mediate thrombosis in patients … tumor metastasis; the enhanced
procoagulant activity of tissue factor after chemotherapy makes many cancer patients more …
procoagulant activity of tissue factor after chemotherapy makes many cancer patients more …
[PDF][PDF] 糖尿病肾病致凝血异常的研究
于牧鑫， 马瑞爽， 司宇， 吴晓明， 邓瑞娟… - 现代生物医学 …, 2015 - biomed.cnjournals.com
… cell that decreased anticoagulant activity. Moreover, the increased procoagulant factor Xa …
of key oncogenic driver mutations in non-small cell lung carcinoma[J]. PLoS One, 2012, 7(2): …
of key oncogenic driver mutations in non-small cell lung carcinoma[J]. PLoS One, 2012, 7(2): …
[PDF][PDF] STS 联合吉非替尼对NSCLC 患者血小板活化功能及炎症因子的影响
瞿小应， 杜旋 - 中南医学科学杂志, 2021 - nhqks.cnjournals.com
… and inflammatory factors in patients with advanced non-small cell lung cancer (NSCLC) …
Enhanced procoagulant activity of platelets after chemotherapy in non-small cell lung cancer…
Enhanced procoagulant activity of platelets after chemotherapy in non-small cell lung cancer…
组织因子途径抑制物与妊娠相关疾病的研究现状
李冰， 徐婷婷， 朱丽丽， 李宁… - 中华妇幼临床医学 …, 2021 - zhfylcyxzz.cma-cmc.com.cn
… Increased circulating procoagulant and anticoagulant factors as TF and TFPI according to
severity or infecting serotypes in human dengue infection[J]. Microbes Infect, 2017, 19(1): 62-…
severity or infecting serotypes in human dengue infection[J]. Microbes Infect, 2017, 19(1): 62-…
[HTML][HTML] 组织因子在肺癌中的研究进展
C XU, X FU - ncbi.nlm.nih.gov
… 小细胞肺癌(small cell lung cancer, SCLC)早期侵犯和转移能力… TF较非小细胞肺癌(non-small
cell lung cancer, NSCLC)高 [9] ，… -associated tissue factor activity in cancer patients with and …
cell lung cancer, NSCLC)高 [9] ，… -associated tissue factor activity in cancer patients with and …
血小板源性细胞外囊泡对创伤性脑损伤诱导凝血功能障碍和炎症反应中的作用
L Liu, QJ Deng - 中国神经再生研究(英文版), 2022 - sjzsyj.com.cn
… Therefore, the procoagulant activity of pEVs is partly related to increasing activity of TF (Rosas
et al., 2020). In addition, Tripisciano et al. (2017) found that pEVs are unable to facilitate …
et al., 2020). In addition, Tripisciano et al. (2017) found that pEVs are unable to facilitate …
[PDF][PDF] 肺癌细胞株中GEM 和CDDP 药物敏感性相关基因的研究
杨春雨， 田振囡， 刘炜， 蔡莉 - 2009 - scholar.archive.org
… 小细胞肺癌(small cell lung cancer, SCLC)和非小细胞肺癌(non-small cell lung cancer, NSCLC)…
sensitivity gene might clarify the action mechanism of anti-cancer drugs and provide a new …
sensitivity gene might clarify the action mechanism of anti-cancer drugs and provide a new …
细胞微囊泡/外泌体在肺部疾病中的应用
罗登， 冉文卓， 叶迎春， 高凌 - 中国组织工程研究, 2018 - cjter.com
… Factors influencing the level of circulating procoagulant … enoxaparin in cancer patients
with elevated tissue factor-bearing … of non-small-cell lung cancer. Biomark Med. 2011;5(6):822. …
with elevated tissue factor-bearing … of non-small-cell lung cancer. Biomark Med. 2011;5(6):822. …